Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,016
datasets available to search
ShareScore release 0.9.0
Dataset results
1,016 results for “Precursors”
Safety & Efficacy of Intramyocardial Injection of Mesenchymal Precursor Cells on Myocardial Function in LVAD Recipients
ClinicalTrials.gov study NCT02362646. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Phase 3 Trial of Blinatumomab vs Standard Chemotherapy in Pediatric Subjects With HIgh-Risk (HR) First Relapse B-precursor Acute Lymphoblastic Leukemia (ALL)
ClinicalTrials.gov study NCT02393859. IPD Sharing: YES. Countries: 24. Publications: 3.
Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma
ClinicalTrials.gov study NCT06533748. IPD Sharing: YES. Countries: 1. Publications: 0.
NAD+ Precursor Supplementation in Friedreich's Ataxia
ClinicalTrials.gov study NCT04817111. IPD Sharing: NO. Countries: 1. Publications: 2.
Dose Response to the Norepinephrine Precursor Droxidopa in Hypotensive Individuals With Spinal Cord Injury
ClinicalTrials.gov study NCT03602014. IPD Sharing: NO. Countries: 1. Publications: 119.
Evaluate the Hematological Remission Rates and Survival Among Chinese Adult Patients With B-precursor ALL
ClinicalTrials.gov study NCT03123887. IPD Sharing: NO. Countries: 1. Publications: 11.
Nonmyeloablative Haploidentical Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Sickle Cell Disease
ClinicalTrials.gov study NCT03077542. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Blinatumomab and Nivolumab With or Without Ipilimumab in Treating Patients With Poor-Risk Relapsed or Refractory CD19+ Precursor B-Lymphoblastic Leukemia
ClinicalTrials.gov study NCT02879695. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Blinatumomab in Adults With Relapsed/Refractory Philadelphia Positive B-precursor Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT02000427. IPD Sharing: NO. Countries: 5. Publications: 8.
Identifying Precursors to Severe Problem Behavior
ClinicalTrials.gov study NCT04097431. IPD Sharing: Not stated. Countries: 1. Publications: 4.
The Effect of Intramyocardial Injection of Mesenchymal Precursor Cells on Myocardial Function in Patients Undergoing LVAD Implantation
ClinicalTrials.gov study NCT01442129. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety of the BiTE Antibody Blinatumomab in Chinese Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)
ClinicalTrials.gov study NCT03476239. IPD Sharing: YES. Countries: 1. Publications: 1.
Study of the BiTE® Blinatumomab (MT103) in Adult Patients With Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia (ALL)
ClinicalTrials.gov study NCT01209286. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.
ClinicalTrials.gov study NCT02032004. IPD Sharing: YES. Countries: 2. Publications: 1.
A Study Evaluating the Safety and Efficacy of Brexucabtagene Autoleucel (KTE-X19) in Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ZUMA-3)
ClinicalTrials.gov study NCT02614066. IPD Sharing: YES. Countries: 5. Publications: 4.
Phase II Study of the BiTE® Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor Acute Lymphoblastic Leukemia (ALL)
ClinicalTrials.gov study NCT00560794. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Study of Blinatumomab in Japanese Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT02412306. IPD Sharing: YES. Countries: 1. Publications: 4.
Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor Acute Lymphoblastic Leukemia (ALL)
ClinicalTrials.gov study NCT01207388. IPD Sharing: Not stated. Countries: 11. Publications: 5.
Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)
ClinicalTrials.gov study NCT01466179. IPD Sharing: Not stated. Countries: 6. Publications: 6.
Nonmyeloablative Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Sickle Cell Disease and Beta-thalassemia in People With Higher Risk of Transplant Failure
ClinicalTrials.gov study NCT02105766. IPD Sharing: YES. Countries: 1. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.